Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease-Reference-Cited by-同舟云学术

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease

Published:2015-09 Issue: Volume:132 Page:96-168
ISSN:0301-0082
Container-title:Progress in Neurobiology
language:en
Short-container-title:Progress in Neurobiology

Author:

Bastide Matthieu F.,Meissner Wassilios G.,Picconi Barbara,Fasano Stefania,Fernagut Pierre-Olivier,Feyder Michael,Francardo Veronica,Alcacer Cristina,Ding Yunmin,Brambilla Riccardo,Fisone Gilberto,Jon Stoessl A.,Bourdenx Mathieu,Engeln Michel,Navailles Sylvia,De Deurwaerdère Philippe,Ko Wai Kin D.,Simola Nicola,Morelli Micaela,Groc Laurent,Rodriguez Maria-Cruz,Gurevich Eugenia V.,Quik Maryka,Morari Michele,Mellone Manuela,Gardoni Fabrizio,Tronci Elisabetta,Guehl Dominique,Tison François,Crossman Alan R.,Kang Un Jung,Steece-Collier Kathy,Fox Susan,Carta Manolo,Angela Cenci M.,Bézard Erwan

Publisher

Elsevier BV

Subject

General Neuroscience

Reference1139 articles.

1. Randomized, placebo-controlled study of tolcapone in patients with fluctuating Parkinson disease treated with levodopa-carbidopa. Tolcapone Fluctuator Study Group III;Adler;Arch. Neurol.,1998

2. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature;Ahlskog;Mov. Disord.,2001

3. Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias;Ahmed;Brain,2011

4. Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease;Ahmed;Sci. Transl. Med.,2010

5. Overexpression of GRK6 rescues L-DOPA-induced signaling abnormalities in the dopamine-depleted striatum of hemiparkinsonian rats;Ahmed;Exp. Neurol.,2015

Cited by 361 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson’s Disease;CNS & Neurological Disorders - Drug Targets;2024-04

2. To what extent may aminochrome increase the vulnerability of dopaminergic neurons in the context of Parkinson's disease;The International Journal of Biochemistry & Cell Biology;2024-03

3. Stem Cell Therapy for the Treatment of Parkinson's Disease: What Promise Does it Hold?;Current Stem Cell Research & Therapy;2024-02

4. Cells, pathways, and models in dyskinesia research;Current Opinion in Neurobiology;2024-02

5. Hair Loss: A Well-Known Yet Understudied Symptom in Parkinson’s Disease Patients During Dopaminergic Therapy;Journal of Movement Disorders;2024-01-31